Kinetics of HIV-1 CTL Epitopes Recognized by HLA I Alleles in HIV-Infected Individuals at Times near Primary Infection: The Provir/Latitude45 Study-Reference-Cited by-同舟云学术

Kinetics of HIV-1 CTL Epitopes Recognized by HLA I Alleles in HIV-Infected Individuals at Times near Primary Infection: The Provir/Latitude45 Study

Published:2014-06-25 Issue:6 Volume:9 Page:e100452
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Papuchon Jennifer,Pinson Patricia,Guidicelli Gwenda-Line,Bellecave Pantxika,Thomas Réjean,LeBlanc Roger,Reigadas Sandrine,Taupin Jean-Luc,Baril Jean Guy,Routy Jean Pierre,Wainberg Mark,Fleury Hervé,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference21 articles.

1. Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication;TW Chun;AIDS,2010

2. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy;D Finzi;Science,1997

3. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir;TW Chun;J Clin Invest 2005,2005

4. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy;S Palmer;Proc Natl Acad Sci U S A,2008

5. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies PLoS Pathog;S Eriksson,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trust as a Determinant Factor for Condom Use among Female Sex Workers in Bali, Indonesia;Tropical Medicine and Infectious Disease;2020-08-15

2. Phylogenetic analysis of HIV-1 archived DNA in blood and gut-associated lymphoid tissue in patients receiving antiretroviral therapy: a study from Provir/Latitude45 project;2020-05-05

3. Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles;PLOS ONE;2019-02-27

4. HIV T-Cell Vaccines;HIV Vaccines and Cure;2018

5. Therapeutic Vaccine Against HIV, Viral Variability, Cytotoxic T Lymphocyte Epitopes, and Genetics of Patients;AIDS Research and Human Retroviruses;2018-01